✦ LIBER ✦

Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients

✍ Scribed by V. S. BLANCHETTE; A. D. SHAPIRO; R. J. LIESNER; F. HERNÁNDEZ NAVARRO; I. WARRIER; P. C. SCHROTH; G. SPOTTS; B. M. EWENSTEIN; FOR THE rAHF-PFM CLINICAL STUDY GROUP

Book ID: 109152589
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 222 KB
Volume: 6
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2008.03032.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation of an advanced categ

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

✍ M. D. Tarantino; P. W. Collins; C. R. M. Hay; A.D. Shapiro; R. A. Gruppo; E. Ber 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Clinical observation on safety and effic

Clinical observation on safety and efficacy of a plasma- and albumin-free recombinant factor VIII for on-demand treatment of Chinese patients with haemophilia A

✍ L. ZHANG; Y. ZHAO; J. SUN; X. WANG; M. YU; R. YANG 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Safety and efficacy of a sucrose-formula

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

✍ J. SHI; Y. ZHAO; J. WU; J. SUN; L. WANG; R. YANG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Efficacy and inhibitor development in pr

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII

✍ Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB